Back to results
US 10,705,076 B2Granted
Anti-HLA monoclonal chimeric immunoglobulin, method and kit implementing such a monoclonal chimeric immunoglobulin
AssigneesUniversite Paul Sabatier Toulouse III, Centre Hospitalier Universitaire De Toulouse
InventorsAntoine Blancher, Nicolas Congy, Jean-Gerard Tiraby, Daniel Drocourt
Life of this patent
Estimating the term…
Abstract
A method for determining the quantity of anti-HLA antibodies of a liquid medium containing antibodies.
Claims7
A process for producing a calibration curve, the process comprising:
- preparing a plurality of solutions (Sn) of a monoclonal chimeric immunoglobulin, each solution (Sn) having a defined concentration value (Cn) of said monoclonal chimeric immunoglobulin, and then
- placing each solution (Sn) in contact with the same defined quantity of at least one immobilized HLA class II antigen, and
- producing the calibration curve, in which each defined concentration value (Cn) is associated with a measured value (Vn) of a parameter, said measured value (Vn) representing a quantity (Qn) of the monoclonal chimeric immunoglobulin linked to the defined quantity of each immobilized HLA class II antigen,
- forming from pairs (Cn, Vn) of defined concentration (Cn) and measured value (Vn), the calibration curve showing the variation of the measured value (Vn) as a function of the defined concentration (Cn) of monoclonal chimeric immunoglobulin of each solution (Sn) of monoclonal chimeric immunoglobulin,
- wherein the monoclonal chimeric immunoglobulin consists of:
- two polypeptide heavy chains (H) of molecular weight from 40 kDa to 60 kDa, and
- two polypeptide light chains (L) of molecular weight from 20 kDa to 30 kDa, wherein:
- each heavy chain (H) comprises:
- a heavy chain variable region (VH) of a monoclonal antibody selected from the group consisting of monoclonal antibodies specific to monomorphic epitopes of HLA class II, and
- a heavy chain constant region (CH) of a human immunoglobulin selected from the group consisting of IgAs, IgGs and IgMs,
- and wherein:
- each light chain (L) comprises:
- a light chain variable region (VL) of a monoclonal antibody selected from the group consisting of monoclonal antibodies specific to monomorphic epitopes of HLA class II antigens, and
- a light chain constant region (CO of a human immunoglobulin that is a kappa chain
- and wherein the two polypeptide heavy chains (H) are identical and the two polypeptide light chains (L) are identical, where
- light chains (L) are of sequence SEQ ID NO:
- 5, and
- heavy chains (H) are identical and selected from the group consisting of sequence SEQ ID NO:
- 6, sequence SEQ ID NO:
- 7 and sequence SEQ ID NO:
- 8.
18 more elements
Dependencies are inferred from the claim text.